Meeting
2016 Genitourinary Cancers Symposium
A non-invasive urine exosome gene expression assay (ExoIntelliScore Prostate) to predict pathologic stage and grade in the prostatectomy specimen.
Authors
Michael Donovan
Icahn School of Medicine at Mount Sinai, New York, NY
Michael Donovan , James Andrew Eastham , Vipul Patel , James M McKiernan , Mikkel Noerholm , Susan Belzer , Stefan Bentink , Vince O'Neill
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 46)
DOI
10.1200/jco.2016.34.2_suppl.46
Abstract #
46
Poster Bd #
C6
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Interim performance of a non-DRE urine exosome gene signature to predict Gleason ≥7 prostate cancer on initial prostate needle biopsy from patients enrolled in a prospective observational trial.
First Author: Michael J. Donovan
Poster
2015 Genitourinary Cancers Symposium
A first catch, non-DRE urine exosome gene signature to predict Gleason 7 prostate cancer on an initial prostate needle biopsy.
First Author: Michael J. Donovan
Poster
2019 Genitourinary Cancers Symposium
Molecular and imaging correlates of exceptional pathologic response to neoadjuvant ADT plus enzalutamide.
First Author: Adam G. Sowalsky
Poster
2015 Genitourinary Cancers Symposium
Molecular and clinical characterization of 1,577 primary prostate cancer tumors to reveal novel clinical and biological insights into its subtypes.
First Author: Felix Yi-Chung Feng